Maternal spindle transfer overcomes embryo developmental arrest caused by ooplasmic defects in mice.
Infertility
Spindle transfer
cell biology
developmental biology
embryo development
heteroplasmy
mitochondrial DNA
mouse
oocytes
Journal
eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614
Informations de publication
Date de publication:
29 04 2020
29 04 2020
Historique:
received:
20
05
2019
accepted:
29
04
2020
pubmed:
30
4
2020
medline:
30
3
2021
entrez:
30
4
2020
Statut:
epublish
Résumé
The developmental potential of early embryos is mainly dictated by the quality of the oocyte. Here, we explore the utility of the maternal spindle transfer (MST) technique as a reproductive approach to enhance oocyte developmental competence. Our proof-of-concept experiments show that replacement of the entire cytoplasm of oocytes from a sensitive mouse strain overcomes massive embryo developmental arrest characteristic of non-manipulated oocytes. Genetic analysis confirmed minimal carryover of mtDNA following MST. Resulting mice showed low heteroplasmy levels in multiple organs at adult age, normal histology and fertility. Mice were followed for five generations (F5), revealing that heteroplasmy was reduced in F2 mice and was undetectable in the subsequent generations. This pre-clinical model demonstrates the high efficiency and potential of the MST technique, not only to prevent the transmission of mtDNA mutations, but also as a new potential treatment for patients with certain forms of infertility refractory to current clinical strategies. Infertility is a growing problem that affects millions of people worldwide. Medical procedures known as in vitro fertilization (IVF) help many individuals experiencing infertility to have children. Typically in IVF, a woman’s egg cells are collected, fertilized with sperm from a chosen male and grown for a few days in a laboratory, before returning them to the woman’s body to continue to develop. However, there are some women whose egg cells cannot develop into a healthy baby after they have been fertilized. Many of these patients use egg cells from donors, instead. This greatly improves the chances of the IVF treatment being successful, but the resultant children are not genetically related to the intended mothers. Previous studies suggested that a cell compartment known as the cytoplasm plays a crucial role in allowing fertilized egg cells to develop normally. A new technique known as maternal spindle transfer, often shortened to MST, makes it possible to replace the entire cytoplasm of a compromised egg cell. This is achieved by transplanting the genetic material of the compromised egg cell into a donor egg cell with healthier cytoplasm that has previously had its own genetic material removed. Using this technique, it is possible to generate human egg cells for IVF that have the genetic material from the intended mother without the defects in the cytoplasm that may be responsible for infertility. However, it is not clear whether this approach would be a safe and effective way to treat infertility in humans. Costa-Borges et al. applied MST to infertile female mice and found that the technique could permanently correct deficiencies in the cytoplasms of poor quality egg cells, allowing the mice to give birth to healthy offspring. Further experiments studied the offspring and their descendants over several generations and found that they also had higher quality egg cells and normal levels of fertility. These findings open up the possibility of developing new treatments for infertility caused by problems with egg cells, so experiments involving human egg cells are now being performed to evaluate the safety and effectiveness of the technique.
Autres résumés
Type: plain-language-summary
(eng)
Infertility is a growing problem that affects millions of people worldwide. Medical procedures known as in vitro fertilization (IVF) help many individuals experiencing infertility to have children. Typically in IVF, a woman’s egg cells are collected, fertilized with sperm from a chosen male and grown for a few days in a laboratory, before returning them to the woman’s body to continue to develop. However, there are some women whose egg cells cannot develop into a healthy baby after they have been fertilized. Many of these patients use egg cells from donors, instead. This greatly improves the chances of the IVF treatment being successful, but the resultant children are not genetically related to the intended mothers. Previous studies suggested that a cell compartment known as the cytoplasm plays a crucial role in allowing fertilized egg cells to develop normally. A new technique known as maternal spindle transfer, often shortened to MST, makes it possible to replace the entire cytoplasm of a compromised egg cell. This is achieved by transplanting the genetic material of the compromised egg cell into a donor egg cell with healthier cytoplasm that has previously had its own genetic material removed. Using this technique, it is possible to generate human egg cells for IVF that have the genetic material from the intended mother without the defects in the cytoplasm that may be responsible for infertility. However, it is not clear whether this approach would be a safe and effective way to treat infertility in humans. Costa-Borges et al. applied MST to infertile female mice and found that the technique could permanently correct deficiencies in the cytoplasms of poor quality egg cells, allowing the mice to give birth to healthy offspring. Further experiments studied the offspring and their descendants over several generations and found that they also had higher quality egg cells and normal levels of fertility. These findings open up the possibility of developing new treatments for infertility caused by problems with egg cells, so experiments involving human egg cells are now being performed to evaluate the safety and effectiveness of the technique.
Identifiants
pubmed: 32347793
doi: 10.7554/eLife.48591
pii: 48591
pmc: PMC7259950
doi:
pii:
Substances chimiques
DNA, Mitochondrial
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : European Regional Development Fund
ID : RD-15-1-0011
Pays : International
Organisme : NIH HHS
ID : 1R01HD092550-01
Pays : United States
Informations de copyright
© 2020, Costa-Borges et al.
Déclaration de conflit d'intérêts
NC, KS, IM, EM, RB, AS, MG, IV, JG, KR, DW, GC No competing interests declared
Références
Aging Cell. 2002 Oct;1(1):40-6
pubmed: 12882352
N Engl J Med. 1990 Oct 25;323(17):1157-60
pubmed: 2136370
Hum Reprod. 2000 Sep;15(9):1997-2002
pubmed: 10967003
Cancer Res. 1970 Mar;30(3):834-6
pubmed: 5425297
Reproduction. 2012 Sep;144(3):331-8
pubmed: 22736797
Methods Mol Biol. 2007;371:191-207
pubmed: 17634583
Curr Opin Obstet Gynecol. 2006 Aug;18(4):418-26
pubmed: 16794423
Reprod Biomed Online. 2017 Apr;34(4):361-368
pubmed: 28385334
Mitochondrion. 2011 Sep;11(5):797-813
pubmed: 20933103
Nature. 2004 Mar 11;428(6979):145-50
pubmed: 15014492
Lab Invest. 1973 Sep;29(3):278-81
pubmed: 4744087
Nat Med. 2012 Feb 26;18(3):413-21
pubmed: 22366948
Genetics. 1997 Feb;145(2):445-51
pubmed: 9071597
Hum Reprod Update. 2018 May 1;24(3):245-266
pubmed: 29432538
Stem Cell Reports. 2017 Mar 14;8(3):576-588
pubmed: 28242217
Hum Reprod. 2014 Apr;29(4):852-9
pubmed: 24524987
Nature. 2010 May 6;465(7294):82-5
pubmed: 20393463
Reprod Biol Endocrinol. 2017 Oct 2;15(1):77
pubmed: 28969648
J Assist Reprod Genet. 2007 Oct;24(10):445-9
pubmed: 17726643
Cell. 2012 Oct 12;151(2):333-343
pubmed: 23063123
Reprod Biomed Online. 2012 Jun;24(6):589-90
pubmed: 22663770
Methods Mol Biol. 2014;1154:171-231
pubmed: 24782010
Cloning Stem Cells. 2007 Summer;9(2):237-46
pubmed: 17579556
PLoS Genet. 2015 Jun 03;11(6):e1005241
pubmed: 26039092
Nat Genet. 1997 May;16(1):93-5
pubmed: 9140402
Fertil Steril. 2018 Jul 15;110(2):185-324.e5
pubmed: 30053940
Nature. 1984 Jan 12-18;307(5947):174-5
pubmed: 6690997
Hum Reprod. 2003 Sep;18(9):1903-7
pubmed: 12923147
Fertil Steril. 2019 Jan;111(1):86-96
pubmed: 30477915
Nature. 2013 Jan 31;493(7434):632-7
pubmed: 23254936
Reproduction. 2006 Feb;131(2):233-45
pubmed: 16452717
Br Med J (Clin Res Ed). 1983 Mar 12;286(6368):835-8
pubmed: 6403104
Biol Reprod. 2004 Nov;71(5):1724-9
pubmed: 15269097
Cell Reprogram. 2010 Aug;12(4):437-46
pubmed: 20698782
J Cell Sci. 1991 Oct;100 ( Pt 2):289-98
pubmed: 1721916
Science. 2016 Jan 22;351(6271):337-9
pubmed: 26797999
Mol Hum Reprod. 1998 Mar;4(3):269-80
pubmed: 9570273
Nature. 2016 Dec 8;540(7632):270-275
pubmed: 27919073
Curr Top Dev Biol. 2007;77:51-83
pubmed: 17222700
J Assist Reprod Genet. 2015 Sep;32(9):1343-58
pubmed: 26276431
Hum Reprod. 2002 Aug;17(8):2165-73
pubmed: 12151453
Hum Reprod. 2016 Oct;31(10):2331-8
pubmed: 27591230
Hum Reprod. 1995 Dec;10 Suppl 2:91-7
pubmed: 8745306
Nature. 2016 Jun 08;534(7607):383-6
pubmed: 27281217
Reprod Fertil Dev. 1996;8(4):485-9
pubmed: 8870074
Obstet Gynecol Int. 2013;2013:183024
pubmed: 23766762
J Assist Reprod Genet. 2009 Jan;26(1):35-9
pubmed: 19096925
Sci Rep. 2019 Apr 30;9(1):6694
pubmed: 31040316
Hum Reprod. 2017 Apr 1;32(4):725-732
pubmed: 28333265
Fertil Steril. 2017 Nov;108(5):742-747
pubmed: 29101999
Nature. 2009 Sep 17;461(7262):367-72
pubmed: 19710649
Hum Reprod. 2017 May 1;32(5):1100-1107
pubmed: 28333293
Curr Opin Obstet Gynecol. 2015 Jun;27(3):175-81
pubmed: 25719756
Fertil Steril. 1999 Mar;71(3):575-7
pubmed: 10065803
Fertil Steril. 1999 Oct;72(4):702-6
pubmed: 10521114
Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1655-60
pubmed: 11172006
Hum Reprod. 1995 Feb;10(2):415-24
pubmed: 7769073
Biology (Basel). 2017 Sep 18;6(3):
pubmed: 28927010
Hum Cell. 1997 Mar;10(1):21-38
pubmed: 9234062
Hum Reprod. 1999 Sep;14(9):2357-61
pubmed: 10469710